Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6364168 | 0.93 | POLB (0.58) | CA12CA1CA2CA9POLB | |
| SCHEMBL26999436 | 0.85 | MAPT (0.40) | CA12CA1CA2CA9POLB | |
| SCHEMBL7088667 | 0.85 | CA12 (0.49) | CA12CA1CA2CA9POLB | |
| SCHEMBL13321997 | 0.85 | POLB (0.66) | POLBMAPTGAANPSR1MEN1 | |
| SCHEMBL4262591 | 0.83 | KMT2A (0.55) | CA12CA1CA2CA9POLB | |
| SCHEMBL26999443 | 0.83 | NPSR1 (0.44) | CA12CA1CA2CA9POLB | |
| SCHEMBL2281034 | 0.82 | POLB (0.68) | POLBMAPTNPSR1MEN1KMT2A | |
| SCHEMBL23357398 | 0.82 | PTPN2 (0.49) | CA12CA1CA2CA9POLB | |
| SCHEMBL9713112 | 0.81 | POLB (0.72) | CA12CA1CA2CA9POLB | |
| SCHEMBL9483480 | 0.81 | MAPT (0.48) | CA12CA1CA2CA9POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1137326-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL CO (JP) | 2006-07-05 | — | — | EP | disclosed |
| US-6878822-B2 | Ethylene derivative having a nitrogen-containing 7-membered ring | FUJI PHOTO FILM CO., LTD. (JP) | 2005-04-12 | — | — | US | disclosed |
| US-20030065171-A1 | Luminescent element material, luminescent element, ethylene derivative having n-containing 7-membered ring, and benzoazepine derivative | FUJI PHOTO FILM CO., LTD. | 2003-04-03 | — | — | US | disclosed |
| US-6413657-B1 | FOR USE IN ELECTRICAL DEVICES AND IN ELECTROPHOTOGRAPHY PHOTORECEPTORS | FUJI PHOTO FILM CO., LTD. (JP) | 2002-07-02 | — | — | US | disclosed |
| EP-1137326-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Nippon Steel Chemical Co., Ltd. (JP) | 2001-09-26 | — | — | EP | disclosed |
| US-5270140-A | Bisstyryl compound and the electrophotographic photoreceptors relating thereto | KONICA CORPORATION (JP) | 1993-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065171-A1 | Luminescent element material, luminescent element, ethylene derivative having n-containing 7-membered ring, and benzoazepine derivative | EPN1, ERLIN1, NUCB2 | CA12 2196/4885CA1 763/4885CA2 2975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.